Clinical Trial Update: Use of PEA and Scutellaria in Synergy With Therapeutic Exercise in Chemotherapy-induced Peripheral Neuropathy (CIPN): a Clinical Trial

View source ↗

Summary

Registration for a clinical trial evaluating the potential synergy of palmitoylethanolamide (PEA) and Scutellaria baicalensis extract together with therapeutic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy
• Neuropathic Pain

Drugs mentioned

• Palmitoylethanolamide (PEA) (palmitoylethanolamide)
• Scutellaria baicalensis extract (scutellaria baicalensis extract)

Snippet

Sponsor: University of Palermo | Conditions: Chemotherapy-induced Peripheral Neuropathy (CIPN), Neuropathic Pain | Status: RECRUITING